Key result
An elevated heart failure echocardiography index was an independent risk factor for one-year adverse events in heart failure patients (OR 1.263), with a cutoff of 3.5 predicting poor prognosis.
Why the study?
The study was designed to investigate the clinical value of the heart failure echocardiography index in evaluating cardiac function and predicting prognosis across different types of heart failure.
Does the heart failure echocardiography index (HFEI) predict one-year adverse events in patients with heart failure?
Observational (n=489)
No
Does the heart failure echocardiography index (HFEI) predict one-year adverse events in patients with heart failure?
The heart failure echocardiography index (HFEI) is an independent predictor of short-term prognosis across different ejection fraction phenotypes of heart failure.
Answers are grounded in this paper and cite their sources.
HFEI may aid prognostic stratification across HF phenotypes; leaves open its added value beyond standard indices in prospective validation.
BACKGROUND: To investigate the clinical value of heart failure echocardiography index (HFEI) in evaluating the cardiac function and predicting the prognosis of patients with different types of heart failure (HF). METHODS: Four hundred eighty-nine consecutively admitted HF patients were divided into three groups: HF with reduced ejection (HFrEF), HF with mid-range ejection fraction (HFmrEF), and HF with preserved ejection fraction (HFpEF). The baseline characteristics and ultrasound indexes were compared between the three groups. The correlation between HFEI and one-year risk of adverse events was compared by multivariate logistic regression. The clinical value of HFEI and plasma level of NT-proBNP in assessing the prognosis of patients with chronic heart failure (CHF) was analyzed by the receiver operating characteristic (ROC) curve. RESULTS: HFEI in HFrEF was significantly higher than that in HFmrEF and HFpEF. Multivariate regression analysis indicated that HFEI and plasma level of NT-proBNP were independent risk factors for predicting the short-time prognosis of HF patients. The ROC curve indicated that the HFEI cutoff level of 3.5 and the plasma NT-proBNP level of 3000 pg/ml predicted a poor prognosis of CHF patients with a sensitivity of 64% and a specificity of 75% vs. 68 and 65%. CONCLUSION: HFEI can comprehensively evaluate the overall cardiac function of patients with various types of HF, and may prove to be an important index of assessing the prognosis of HF patients.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) conducted an observational in Heart failure (n=489). Heart failure echocardiography index (HFEI) was evaluated on One-year adverse events (all-cause death, cardiovascular death, and hospitalization for HF exacerbation) (OR 1.263, 95% CI 1.040-1.533, p=0.019). An elevated heart failure echocardiography index was an independent risk factor for one-year adverse events in heart failure patients (OR 1.263), with a cutoff of 3.5 predicting poor prognosis.
Synapse has enriched 10 related papers. Consider them for comparative context: